Immunopathology of Japanese macaque encephalomyelitis is similar to multiple sclerosis

Tiffany C Blair1, Minsha Manoharan1, Stephanie D Rawlings-Rhea1

  • 1Vaccine and Gene Therapy Institute, Oregon Health & Science University (OHSU), 505 NW 185th Avenue, Beaverton, OR 97006, United States.

Journal of Neuroimmunology
|February 10, 2016
PubMed

Insights

Japanese macaque encephalomyelitis (JME) is an inflammatory brain disease in macaques resembling multiple sclerosis. Studies indicate JME is immune-mediated, with active lesions in the central nervous system showing inflammatory markers.

Area of Science:

  • Neuroimmunology
  • Comparative Pathology
  • Primate Models

Background:

  • Japanese macaque encephalomyelitis (JME) is a spontaneous inflammatory demyelinating disease in Japanese macaques (JM).
  • Clinical and MRI findings in JME resemble human multiple sclerosis (MS).

Purpose of the Study:

  • To investigate if JME exhibits characteristics of an immune-mediated central nervous system (CNS) disease.
  • To compare the immunological features of JME lesions with those of MS.

Main Methods:

  • Analysis of CNS lesions in JME-affected macaques.
  • Immunohistochemical staining for inflammatory markers (IL-17, T cell subsets).
  • Cerebrospinal fluid (CSF) analysis.

Main Results:

  • JME lesions showed positive staining for IL-17.
  • Active lesions contained CD4+ T cells with Th1 and Th17 phenotypes, and CD8+ T cells.
  • CSF findings were consistent with an inflammatory CNS process.

Conclusions:

  • JME shares key immunological features with immune-mediated CNS diseases like MS.
  • The presence of specific T cell subsets and inflammatory markers supports an immune-mediated etiology for JME.
  • JME serves as a relevant preclinical model for studying immune-mediated demyelinating diseases.